Physician

Sramila Aithal, MD

According to 2025 Medicare claims, Sramila Aithal, MD (NPI: 1205029816) practices hematology/oncology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is ALLIANCE CANCER SPECIALISTS P.C. (NPI: 1487923686; TIN: 452552343) and primary practice location at 19020-6415.

Aithal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 375 traditional Medicare patients, billed 94,573 HCPCS/CPT codes, and received $1,579,863 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,227 prescription claims across 242 beneficiaries totaling $1,933,797 in drug costs, led by Ibrance (Palbociclib). DME data shows 14 claims. Open Payments data shows 116 records totaling $141,011. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $18,175 to $1,579,863. Similarly, Part D prescription costs have moved sharply higher in recent years, from $306,008 to $1,933,797. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	106	315	$18,175
2016	137	473	$28,425
2017	161	531	$33,914
2018	176	619	$46,466
2019	173	616	$47,676
2020	182	603	$43,227
2021	242	8,512	$145,475
2022	279	62,465	$613,832
2023	270	99,589	$1,388,828
2024	375	94,573	$1,579,863

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	59	285	$306,008
2016	72	499	$447,045
2017	93	563	$519,353
2018	103	684	$1,256,336
2019	109	594	$1,461,021
2020	116	495	$919,992
2021	143	377	$685,408
2022	189	876	$1,304,774
2023	217	1,075	$1,498,033
2024	242	1,227	$1,933,797

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	102	$55,066
2016	N/R	116	$52,265
2017	N/R	107	$18,269
2018	N/R	40	$7,783
2019	N/R	22	$883
2020	N/R	94	$8,529
2021	N/R	47	$3,066
2022	N/R	16	$882
2023	N/R	N/R	N/R
2024	N/R	14	$1,630

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	58	94	$153
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	191	412	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	91	99	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	181	263	$14
96372	Injection of drug or substance under skin or into muscle	77	229	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	64	1,792	$1,006,465
Kisqali	Ribociclib Succinate	13	364	$177,868
Eliquis	Apixaban	67	2,430	$45,522
Xarelto	Rivaroxaban	17	1,170	$20,576
Exemestane	Exemestane	48	3,828	$6,752

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	14	$1,630

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$141,011	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sramila Aithal, MD?

Tedicare shows public-source Medicare data for Sramila Aithal, MD (NPI 1205029816), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sramila Aithal, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sramila Aithal, MD?

Sramila Aithal, MD is linked to ALLIANCE CANCER SPECIALISTS P.C. (billing NPI 1487923686) in the available physician profile data.

Does Sramila Aithal, MD have Open Payments data?

Sramila Aithal, MD has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.